Objective: To determine the cell surface autoimmune target of herpetiform p
emphigus (HP).
Design: Serum samples of HP were examined by immunoblot studies with human
epidermal extracts, enzyme-linked immunosorbent assay with baculovirus-expr
essed recombinant desmoglein (rDsg) 1 and rDsg3, and immunoadsorption assay
with rDsg.
Patients: Twenty serum samples were obtained from patients with HP who have
typical clinical and histological features. All serum samples showed posit
ive staining against keratinocyte cell surfaces by indirect immunofluoresce
nce studies with healthy human skin. Results: Immunoblot results showed tha
t of 17 HP serum samples, only 5 reacted with a 160-kd band and 1 reacted w
ith a 130-kd band.
Results of enzyme-linked immunosorbent assays with rDsg1 and rDsg3 demonstr
ated that of 20 HP serum samples, 16 were positive against Dsg1 and 4 were
positive against Dsg3. No serum samples reacted with both. Furthermore, in
19 of 20 HP serum samples, immunoreactivity against keratinocyte cell surfa
ces was completely removed by preincubation with rDsg 1 and rDsg3 as shown
by indirect immunofluorescence, excluding a possibility that these HP sera
contain autoantibodies against other cell surface molecules.
Conclusions: Dsg1 and Dsg3 are the major cell surface target molecules of H
P, suggesting that most cases of HP are clinical variants of pemphigus foli
aceus and that the rest might be variants of pemphigus vulgaris.